Condition
Liposomal Bupivacaine clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Liposomal Bupivacaine clinical trials that are recruiting, at sites in 2 countries (most in China (7), Hong Kong (2)). By phase: Phase 3 (2), Phase 4 (1). The most active sponsors are Beijing Tiantan Hospital (5), The University of Hong Kong (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 2Countries
Newest Liposomal Bupivacaine clinical trials
All recruiting trials (9)
-
Liposomal Bupivacaine Plus Plain Bupivacaine vs Dexamethasone Plus Plain Bupivacaine for High-Risk Pain After Supraclavicular Brachial Plexus Block
This trial tests whether liposomal bupivacaine with plain bupivacaine can better control postoperative pain after distal radial fracture surgery in patients at high risk of severe pain, compared with dexamethasone plus plain bupivacaine.
-
Liposomal Bupivacaine vs Ropivacaine for TAP Block in Laparoscopic Gallbladder Surgery
In people having gallbladder removal with laparoscopy, this study tests whether liposomal bupivacaine for a TAP block reduces pain compared with standard ropivacaine.
-
Liposome-based nerve block to improve recovery after VATS lung surgery
This study tests whether a preoperative intercostal nerve block with liposomal bupivacaine helps people recover better after VATS partial pneumonectomy.
-
Liposomal bupivacaine TAP block to reduce pain after laparoscopic gynecologic cancer surgery
This trial will test whether a long‑acting liposomal form of bupivacaine given as a transversus abdominis plane (TAP) block reduces postoperative pain for adults having laparoscopic gynecologic oncology surgery.
-
Liposomal bupivacaine via transversus abdominis plane block to reduce pain after laparoscopic surgery
This trial will test whether adding liposomal bupivacaine to an ultrasound-guided TAP block reduces postoperative pain and opioid use in adults having elective laparoscopic abdominal surgery.
-
Liposomal bupivacaine for pain after laparoscopic surgery
This trial will test whether a long-acting, liposomal form of bupivacaine given at the incision reduces postoperative pain and the need for oral pain medicines in adults having elective laparoscopic procedures.
-
Liposomal bupivacaine for rhomboid intercostal nerve block to reduce pain after VATS
We will test whether adding long‑acting liposomal bupivacaine to a rhomboid intercostal nerve block reduces pain after video‑assisted thoracoscopic lung surgery in adults.
-
Liposomal bupivacaine to reduce pain after VATS
This test will see if a long‑acting liposomal bupivacaine injection at the incision eases postoperative pain for adults having VATS lung surgery.
-
Different doses of liposomal bupivacaine for adductor canal block after total knee replacement
This will test whether different doses of liposomal bupivacaine given in the adductor canal block reduce pain and opioid use after elective total knee replacement in adults.
Related topics
Quick answers
How many Liposomal Bupivacaine clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (7 trials), Hong Kong (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.